C3 and breast cancer: Cancer cells of BC‐LM and LC‐LM also disrupt the blood–CSF barrier by deriving C3 to activate the C3a receptor in the choroid plexus epithelium to allow plasma amphiregulin and other mitogens entering the CSF, which also promotes cancer cells growth in CSF.35